Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Animal Blood Plasma and Derivatives Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Animal Blood Plasma and Derivatives Market Status and Forecast (2016-2027)
      • 1.3.2 Global Animal Blood Plasma and Derivatives Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Animal Blood Plasma and Derivatives Supply by Company

    • 2.1 Global Animal Blood Plasma and Derivatives Sales Value by Company
    • 2.2 Animal Blood Plasma and Derivatives Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Animal Blood Plasma and Derivatives Market Status by Category

    • 3.1 Animal Blood Plasma and Derivatives Category Introduction
      • 3.1.1 Immunoglobulin
      • 3.1.2 Fibrinogen
      • 3.1.3 Serum Albumin
      • 3.1.4 Fetal Bovine Serum
      • 3.1.5 Thrombin
      • 3.1.6 New Born Calf Serum
    • 3.2 Global Animal Blood Plasma and Derivatives Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Animal Blood Plasma and Derivatives Market Status by End User/Segment

    • 4.1 Animal Blood Plasma and Derivatives Segment by End User/Segment
      • 4.1.1 Food & Beverages
      • 4.1.2 Pharmaceuticals
      • 4.1.3 Cosmetics
      • 4.1.4 Feed
      • 4.1.5 Others
    • 4.2 Global Animal Blood Plasma and Derivatives Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Animal Blood Plasma and Derivatives Market Status by Region

    • 5.1 Global Animal Blood Plasma and Derivatives Market by Region
    • 5.2 North America Animal Blood Plasma and Derivatives Market Status
    • 5.3 Europe Animal Blood Plasma and Derivatives Market Status
    • 5.4 Asia Pacific Animal Blood Plasma and Derivatives Market Status
    • 5.5 Central & South America Animal Blood Plasma and Derivatives Market Status
    • 5.6 Middle East & Africa Animal Blood Plasma and Derivatives Market Status

    6 North America Animal Blood Plasma and Derivatives Market Status

    • 6.1 North America Animal Blood Plasma and Derivatives Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Animal Blood Plasma and Derivatives Market Status

    • 7.1 Europe Animal Blood Plasma and Derivatives Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Animal Blood Plasma and Derivatives Market Status

    • 8.1 Asia Pacific Animal Blood Plasma and Derivatives Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Animal Blood Plasma and Derivatives Market Status

    • 9.1 Central & South America Animal Blood Plasma and Derivatives Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Animal Blood Plasma and Derivatives Market Status

    • 10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Animal Blood Plasma and Derivatives Market Forecast by Category and by End User/Segment

    • 12.1 Global Animal Blood Plasma and Derivatives Sales Value Forecast (2022-2027)
    • 12.2 Global Animal Blood Plasma and Derivatives Forecast by Category
    • 12.3 Global Animal Blood Plasma and Derivatives Forecast by End User/Segment

    13 Global Animal Blood Plasma and Derivatives Market Forecast by Region/Country

    • 13.1 Global Animal Blood Plasma and Derivatives Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Thermo Fisher Scientific, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.1.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Rocky Mountain Biologicals Inc.
      • 14.2.1 Company Information
      • 14.2.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.2.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Proliant Inc.
      • 14.3.1 Company Information
      • 14.3.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.3.3 Proliant Inc. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck KGaA
      • 14.4.1 Company Information
      • 14.4.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.4.3 Merck KGaA Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 LAMPIRE Biological Laboratories, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Lake Immunogenics, Inc.
      • 14.6.1 Company Information
      • 14.6.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Kraeber & Co GmbH
      • 14.7.1 Company Information
      • 14.7.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.7.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bovogen Biologicals Pty Ltd.
      • 14.8.1 Company Information
      • 14.8.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.8.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Auckland BioSciences Ltd.
      • 14.9.1 Company Information
      • 14.9.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 ANZCO Foods Ltd.
      • 14.10.1 Company Information
      • 14.10.2 Animal Blood Plasma and Derivatives Product Introduction
      • 14.10.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Animal Blood Plasma and Derivatives market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Animal Blood Plasma and Derivatives market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Immunoglobulin
      Fibrinogen
      Serum Albumin
      Fetal Bovine Serum
      Thrombin
      New Born Calf Serum

      Segmented by End User/Segment
      Food & Beverages
      Pharmaceuticals
      Cosmetics
      Feed
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific, Inc.
      Rocky Mountain Biologicals Inc.
      Proliant Inc.
      Merck KGaA
      LAMPIRE Biological Laboratories, Inc.
      Lake Immunogenics, Inc.
      Kraeber & Co GmbH
      Bovogen Biologicals Pty Ltd.
      Auckland BioSciences Ltd.
      ANZCO Foods Ltd.
      Buy now